We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Vicapsys Life Sciences (OTC: VICP): Understanding the Deregistered Biomaterials Developer

Vicapsys Life Sciences is a Florida-incorporated, Georgia-based development-stage life-sciences company focused on biomaterials for transplantation and surgical applications. Its lead concept, VICAPSYN, is an immunoisolation technology intended to protect transplanted cells, such as insulin-producing islet cells, from immune rejection, while a second program, VYBRIN, …

Nitish Kishor | 10 September 2026

Sonoma Pharmaceuticals (NASDAQ: SNOA): A Turn Toward Positive Adjusted EBITDA

Sonoma Pharmaceuticals, based in Boulder, Colorado, develops and manufactures products built on its stabilized hypochlorous acid technology, marketed under brands including Microcyn and Microdacyn for wound care and related indications. On June 16, 2026, the company reported fiscal 2026 results, for its fiscal year …

Nitish Kishor | 10 September 2026

KORU Medical Systems (NASDAQ: KRMD): A Return to Profitability in Subcutaneous Delivery

KORU Medical Systems, headquartered in Mahwah, New Jersey, develops and manufactures subcutaneous infusion systems used to deliver medications such as immunoglobulin therapies outside the hospital, led by its FREEDOM syringe infusion platform and the FreedomEDGE device. On August 5, 2026, the company reported second-quarter …

Nitish Kishor | 10 September 2026

Reflect Scientific (OTC: RSCF): Cryogenic Freezers Meet Data-Center Cooling

Reflect Scientific, Inc. (OTC: RSCF), based in Orem, Utah, designs and sells scientific equipment for the life-science andManufacturingsectors, most notably its Cryometrix ultra-low-temperature and blast freezers used to store blood, vaccines and other temperature-sensitive products, along with laboratory consumables. Its most recent operational update …

Nitish Kishor | 10 September 2026

DENTSPLY SIRONA (NASDAQ: XRAY): Progress on the Return-to-Growth Action Plan

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) is one of the world's largest manufacturers of professional dental products and technologies, spanning imaging systems, CAD/CAM equipment, orthodontic clear aligners, implants, endodontic tools and consumables. On August 6, 2026, the company reported second-quarter 2026 results that captured its …

Nitish Kishor | 10 September 2026

Premier Biomedical (OTC: BIEI): The Pivot From Biomedical Research to Graphene Defense

Premier Biomedical, Inc. (OTC: BIEI) historically described itself as a research-based company developing products for conditions such as PTSD, cancer and pain, including hemp-oil-based topical products. Over the past two years it has shifted its focus toward graphene technology and applications, branding that effort …

Nitish Kishor | 10 September 2026

ASP Isotopes (NASDAQ: ASPI): The Long-Range Plan Unveiled at Capital Markets Day

ASP Isotopes Inc. (NASDAQ: ASPI) is an advanced-materials company that enriches and produces isotopes for nuclear medicine, semiconductors and energy, and it has expanded through Renergen's helium andLNGoperations in South Africa and its Quantum Leap Energy nuclear-fuel subsidiary. On September 8, 2026, ASP Isotopes …

Nitish Kishor | 10 September 2026

Encision (OTC: ECIA): What Deregistration Means for the Surgical-Device Maker

Encision Inc. (OTC: ECIA) is a Colorado-based medical-device company known for its Active Electrode Monitoring (AEM) technology, which is designed to prevent stray electrosurgical burns during minimally invasive laparoscopic surgery. In a defining move, Encision's board approved filing a Form 15 to voluntarily deregister …

Nitish Kishor | 10 September 2026

ANI Pharmaceuticals (NASDAQ: ANIP): Cortrophin Gel Drives Record Quarterly Growth

ANI Pharmaceuticals is a diversified drugmaker headquartered in Princeton, New Jersey, operating across three segments: rare disease, generics and established brands. Its flagship product is Cortrophin Gel (repository corticotropin injection), a purified adrenocorticotropic hormone therapy used in conditions spanning rheumatology, neurology and ophthalmology. On …

Nitish Kishor | 10 September 2026

Avoca (AVOA): Why the Ticker's Identity and Listing Status Need Verifying

Efforts to confirm a listed operating company behind the AVOA ticker were inconclusive. Standard market-data pages for AVOA, as either a common stock or an exchange-traded fund, were not available, and a full-text search of U.S. Securities and Exchange Commission filings returned no operating …

Nitish Kishor | 10 September 2026
Support

Hi! How can we help you today?

Loading…